Pemphigus is a potentially fatal autoimmune epidermal bullous disorder. Rituximab is a novel therapy for the treatment of refractory pemphigus. However, there is limited clinical data on safety and efficacy of rituximab in pediatric age group. Herein, we report an…
- Главная страница
- О нас
- Живущих с P/P
- Научные исследования
- Принять участие
- Новости & Информация о
- Discussion Forums
